Specific biochemical entities—such as enzymes, receptors, genetic variants, or signaling molecules—that are uniquely identified in an individual patient as the primary drivers of their particular health deficit or aging phenotype. These targets are determined through advanced diagnostic testing, including genomics, proteomics, and metabolomics. The clinical focus is on creating highly individualized interventions for maximum therapeutic effect.
Origin
This term is a direct outgrowth of the Personalized Medicine revolution, where therapeutic strategies are shifted from population-based averages to individual molecular profiles. It combines the scientific precision of molecular biology with the clinical philosophy of individualized care.
Mechanism
The identification of a personalized molecular target allows for the selection of an intervention—a specific drug, peptide, or nutraceutical—that is known to modulate that exact molecule or pathway. For instance, a patient with a specific gene variant affecting detoxification may be targeted with tailored enzymatic cofactors. This mechanism ensures that therapy is maximally efficient and minimizes off-target effects by focusing on the unique molecular signature of the patient’s physiology.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.